Open AccessA chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients
Author(s) -
Andrew Mitchell,
Sarrah L. Hasanali,
Daley S. Morera,
Rohitha Baskar,
Xin Wang,
Rahil Khan,
Asif Talukder,
Charles S. Li,
Meenakkshy Manoharan,
Andre R. Jordan,
Jiaojiao Wang,
Roni J. Bollag,
Nagendra Singh,
Daniel Albo,
Santu Ghosh,
Vinata B. Lokeshwar
Publication year - 2019
Publication title -
disease markers. section a, cancer biomarkers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.959
H-Index - 41
eISSN - 1875-8592
pISSN - 1574-0153
DOI - 10.3233/cbm-190210
Subject(s) - chemokine , chemokine receptor , medicine , colorectal cancer , oncology , metastasis , cohort , gene signature , ccr2 , immunology , receptor , cancer , biology , gene expression , gene , biochemistry
Differential expression of chemokines/chemokine receptors in colorectal cancer (CRC) may enable molecular characterization of patients' tumors for predicting clinical outcome.